Design and baseline characteristics of the AMPLITUDE-O cardiovascular outcomes trial of efpeglenatide, a weekly GLP-1 RA

Citation
Gerstein HC, Branch K, Heenan L, et al. Diabetes Obes Metab 2020; epub ahead of press.